Role for interferon-γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells

Stem Cells

Volumn 24, Issue 2, 2006, Pages 386-398

  Krampera, Mauro ^a   Cosmi, Lorenzo ^b   Angeli, Roberta ^b   Pasini, Annalisa ^a   Liotta, Francesco ^b   Andreini, Angelo ^a   Santarlasci, Veronica ^b   Mazzinghi, Benedetta ^b   Pizzolo, Giovanni ^a   Vinante, Fabrizio ^a   Romagnani, Paola ^b   Maggi, Enrico ^b   Romagnani, Sergio ^b   Annunziato, Francesco ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Immune suppression; Indoleamine 2,3 dioxygenase; Mesenchymal stem cells

Indexed keywords

GAMMA INTERFERON; CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOLOGIC FACTOR; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 2 RECEPTOR;

ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL ACTIVITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MESENCHYMAL STEM CELL; NATURAL KILLER T CELL; REGULATORY T LYMPHOCYTE; APOPTOSIS; CELL CULTURE; DRUG POTENTIATION; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; METABOLISM; NATURAL KILLER CELL; PHYSIOLOGY; T LYMPHOCYTE; TIME;

ANTIGENS, CD4; ANTIGENS, CD8; APOPTOSIS; B-LYMPHOCYTES; BONE MARROW CELLS; CELL PROLIFERATION; CELLS, CULTURED; DRUG SYNERGISM; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOPHENOTYPING; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE II; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MESENCHYMAL STEM CELLS; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES; TIME FACTORS;

EID: 33746889097     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2005-0008     Document Type: Article

References (51)

1. Fridenshtein A. Stromal bone marrow cells and the hematopoietic microenvironment. Arkh Patol 1982;44:3-11.
2. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
3. Bianco P, Gehron Robey P. Marrow stromal stem cells. J Clin Invest 2000;105:1663-1668.
4. Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995;18:1417-1426.
5. Woodbury D, Schwarz EJ, Prockop DJ et al. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000;61:364-370.
6. Reyes M, Lund T, Lenvik T et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001;98:2615-2625.
7. Peled A, Petit I, Kollet O et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999;283:845-848.
8. Koc ON, Gerson SL, Cooper BW et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000;18:307-316.
9. Pereira RF, Halford KW, O'Hara MD et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A 1995;92:4857-4861.
10. Devine SM, Peter S, Martin BJ et al. Mesenchymal stem cells: Stealth and suppression. Cancer J (suppl 2) S76-S82, 2001.
11. Toma C, Pittenger MF, Cahill KS et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-98.
12. Ferrari G, Cusella-De Angelis G, Coletta M et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998;279:1528-1530.
13. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-705.
14. Petersen BE, Bowen WC, Patrene KD et al. Bone marrow as a potential source of hepatic oval cells. Science 1999;284:1168-1170.
15. Schwartz RE, Reyes M, Koodie L et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 2002;109:1291-1302.
16. Brazelton TR, Rossi FM, Keshet GI et al. From marrow to brain: Expression of neuronal phenotypes in adult mice. Science 2000;290:1775-1779.
17. Mezey E, Chandross KJ, Harta G et al. Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000;290:1779-1782.
18. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-49.
19. Bartholomew A, Patil S, Mackay A et al. Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo. Hum Gene Ther 2001;12:1527-1541.
20. Dejbakhsh-Jones S, Jerabek L, Weissman IL et al. Extrathymic maturation of alpha beta T cells from hemopoietic stem cells. J Immunol 1995;155:3338-3344.
21. Barda-Saad M, Rozenszajn LA, Globerson A et al. Selective adhesion of immature thymocytes to bone marrow stromal cells: relevance to T cell lymphopoiesis. Exp Hematol 1996;24:386-391.
22. Li Y, Hisha H, Inaba M et al. S. Evidence for migration of donor bone marrow stromal cells into recipient thymus after bone marrow transplantation plus bone grafts: A role of stromal cells in positive selection. Exp Hematol 2000;28:950-960.
23. Suniara RK, Jenkinson EJ, Owen JJ. An essential role for thymic mesenchyme in early T cell development. J Exp Med 2000;191:1051-1056.
24. Di Nicola M, Carlo-Stella C, Magni M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99:3838-3843.
25. Krampera M, Glennie S, Laylor R et al. Bone marrow mesenchymal stem cells inhibit the response of naïve and memory antigen-specific T cells to their cognate peptide. Blood 2003;101:3722-3729.
26. Bartholomew A, Sturgeon C, Siatskas M et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002;30:42-48.
27. Ringden O, Labopin M, Bacigalupo A et al. Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia. J Clin Oncol 2002;20:4655-4664.
28. Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-1441.
29. Couriel D, Caldera H, Champlin R et al. Acute graft-versus-host disease: Pathophysiology, clinical manifestations, and management. Cancer 2004;101:1936-1946.
30. + regulatory thymocytes because of their responsiveness to different cytokines. Blood 2004;103:3117-3121.
31. Cosmi L, Annunziato F, Iwasaki M et al. CRTH2 is the most reliable marker for detection of human circulating Th2 and Tc2 cells in health and disease. Eur J Immunol 2000;30:2972-2979.
32. + human thymocytes. J Exp Med 2002;196:379-387.
33. Aubry JP, Blaecke A, Lecoanet Henchoz S et al. Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity. Cytometry 1999;37:197-204.
34. + regulatory thymocytes. Blood 2003;102:4107-4114.
35. + T (h) 2 cells by IL-12 or the PS-DSP30 oligodeoxynucleotide. J Allergy Clin Immunol 2001;108:815-821.
36. Meisel R, Zibert A, Laryea M et al. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase mediated tryptophan degradation. Blood 2004;103:4619-4621.
37. Cady SG, Sono M. 1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase. Arch Biochem Biophys 1991;291:326-333.
38. Connop BP, Kalisch BE, Boegman RJ et al. Enhancement of 7-nitro indazole-induced inhibition of brain nitric oxide synthase by norharmane. Neurosci Lett 1995;190:69-72.
39. Le Blanc K, Tammik L, Sundberg B et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003;57:11-20.
40. Rasmusson I, Ringden O, Sundberg B et al. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003;76:1208-1213.
41. Gotherstrom C, Ringden O, Tammik C et al. Immunological properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 2004;190:239-245.
42. + and NK lymphocytes in the direct cell-to-cell interaction. Clin Immunol 2004;112:258-267.
43. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003;198:1875-1886.
44. Tse WT, Pendleton JD, Beyer WM et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003;75:389-397.
45. Rasmusson I, Ringden O, Sundberg B et al. Mesenchymal stem cell inhibit lymphocytes proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 2005;305:33-41.
46. Le Blanc K, Rasmusson I, Gotherstrom C et al. Mesenchymal stem cell inhibit the expression of CD25 (interleukine-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand J Immunol 2004;60:307-315.
47. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood First Edition Paper, prepublished online October 19, 2004; doi 10.1182/blood-2004-04-1559.
48. Glennie S, Soeiro I, Dyson PJ et al. Bone marrow mesenchymal stem cells induce division arrest energy of activated T cells. Blood 2005;105:2821-2827.
49. Munn DH, Sharma MD, Lee JR et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 2002;297:1867-1870.
50. Frumento G, Rotondo R, Tonetti M et al. Tryptophane-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 2002;196:459-468.
51. Fallarino F, Grohmann U, Hwang KW et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 2003;4:1206-1212.